Has Repro-Med Systems been receiving favorable news coverage?

News articles about REPR stock have trended somewhat positive on Thursday, Accern reports. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Repro-Med Systems earned a coverage optimism score of 0.15 on Accern's scale. They also assigned news stories about the company an impact score of 46.05 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of Repro-Med Systems?

Shares of REPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Repro-Med Systems' stock price today?

One share of REPR stock can currently be purchased for approximately $1.32.

How big of a company is Repro-Med Systems?

Repro-Med Systems has a market capitalization of $52.84 million and generates $12.24 million in revenue each year. Repro-Med Systems employs 69 workers across the globe.

How can I contact Repro-Med Systems?

Repro-Med Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company can be reached via phone at 845-469-2042 or via email at [email protected]

MarketBeat Community Rating for Repro-Med Systems (REPR)

MarketBeat's community ratings are surveys of what our community members think about Repro-Med Systems and other stocks. Vote "Outperform" if you believe REPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe REPR will underperform the S&P 500 over the long term. You may vote once every thirty days.